Company record
PAYLESS COMPOUNDERS, LLC
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about PAYLESS COMPOUNDERS, LLC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Apr 22 | Class II | PAYLESS COMPOUNDERS, LLC Drug |
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR Lack of Assurance of Sterility FDA notice D-0471-2026 |